Patents by Inventor George P. Peruzzotti

George P. Peruzzotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of increasing the percentage of viable dried spores of a fungus
    Patent number: 5288634
    Abstract: This invention relates in part to the use of osmoticants to provide desiccation tolerance to growth producing cells of microorganisms upon drying and reconstitution.This invention also relates in part to the discovery of liquid fermentation media permitting production of high levels of conidia of Trichoderma harzianum in liquid fermentation, and modifications to these media that produce conidia that are resistant to desiccation and that provide enhanced biocontrol efficacy.
    Type: Grant
    Filed: November 13, 1992
    Date of Patent: February 22, 1994
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Gary E. Harman, Xixuan Jin, Thomas E. Stasz, George P. Peruzzotti, A. Carl Leopold, Alan G. Taylor
  • Cycloalkenyl analogues of prostaglandin A
    Patent number: 4138582
    Abstract: Analogues of prostaglandins A, E, and F in which the C.sub.13 -C.sub.20 chain of the natural prostaglandins is replaced by a cycloalkenyl or a hydroxycycloalkenyl moiety such that vinylene radical and the hydroxyl group of the ring respectively retain their natural sequential positions at C.sub.13 -C.sub.14 and C.sub.15, inhibit aggregation of platelets in vitro and exhibit useful cardiovascular activity in vivo.
    Type: Grant
    Filed: June 6, 1977
    Date of Patent: February 6, 1979
    Assignee: Miles Laboratories, Inc.
    Inventors: Warren D. Woessner, William G. Biddlecom, Henry C. Arndt, George P. Peruzzotti, Charles J. Sih
  • Cycloalkenyl analogues of prostaglandin F
    Patent number: 4138583
    Abstract: Analogues of prostaglandins A, E, and F in which the C.sub.13 -C.sub.20 chain of the natural prostaglandins is replaced by a cycloalkenyl or a hydroxycycloalkenyl moiety such that vinylene radical and the hydroxyl group of the ring respectively retain their natural sequential positions at C.sub.13 -C.sub.14 and C.sub.15, inhibit aggregation of platelets in vitro and exhibit useful cardiovascular activity in vivo.
    Type: Grant
    Filed: June 6, 1977
    Date of Patent: February 6, 1979
    Assignee: Miles Laboratories, Inc.
    Inventors: Warren D. Woessner, William G. Biddlecom, Henry C. Arndt, George P. Peruzzotti, Charles J. Sih